In melanoma cells, the HA–CD44 axis increased cell proliferation [137] and promoted the expression of the inhibitor of differentiation/DNA binding (Id) proteins 1 and 3 via the BMP type II receptor (BMPR) to decrease OS in melanoma patients [138]. Here, CD44 is linked to melanoma.